Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12028540rdf:typepubmed:Citationlld:pubmed
pubmed-article:12028540lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:12028540lifeskim:mentionsumls-concept:C0025202lld:lifeskim
pubmed-article:12028540lifeskim:mentionsumls-concept:C0325089lld:lifeskim
pubmed-article:12028540lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:12028540lifeskim:mentionsumls-concept:C0009017lld:lifeskim
pubmed-article:12028540lifeskim:mentionsumls-concept:C0883208lld:lifeskim
pubmed-article:12028540lifeskim:mentionsumls-concept:C1301820lld:lifeskim
pubmed-article:12028540lifeskim:mentionsumls-concept:C2347040lld:lifeskim
pubmed-article:12028540lifeskim:mentionsumls-concept:C1561491lld:lifeskim
pubmed-article:12028540pubmed:issue2lld:pubmed
pubmed-article:12028540pubmed:dateCreated2002-5-24lld:pubmed
pubmed-article:12028540pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12028540pubmed:abstractTextMelanoma antigens (MAGE), thought to induce tumor-specific immune responses, are used as potential therapeutical targets for cancer immunotherapy. We hereby report the cloning and sequencing of MAGE cDNA clone, called feline MAGE-2 (fMAGE-2), obtained from a lymphoma cell line. fMAGE-2 cDNA is 1535 base pairs (bp) in length and contains an open reading frame (ORF) of 1131 bp encoding a protein of 376 amino acids. The predicted amino acid sequence shows 45%, 32-42%, 44-47%, and 33% homology with feline MAGE-1, human MAGE-A, human MAGE-B, and human MAGE-C proteins, respectively. mRNA transcripts of fMAGE-2 were detected by RT-PCR in some feline tumors, as well as in testis of adult cat, but not in other normal tissues, indicating that the expression pattern of fMAGE-2 is similar to that of the human MAGE family genes in tumors and normal tissues.lld:pubmed
pubmed-article:12028540pubmed:languageenglld:pubmed
pubmed-article:12028540pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12028540pubmed:citationSubsetIMlld:pubmed
pubmed-article:12028540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12028540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12028540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12028540pubmed:statusMEDLINElld:pubmed
pubmed-article:12028540pubmed:monthFeblld:pubmed
pubmed-article:12028540pubmed:issn0001-2815lld:pubmed
pubmed-article:12028540pubmed:authorpubmed-author:OkudaMMlld:pubmed
pubmed-article:12028540pubmed:authorpubmed-author:SasakiKKlld:pubmed
pubmed-article:12028540pubmed:authorpubmed-author:OnishiTTlld:pubmed
pubmed-article:12028540pubmed:authorpubmed-author:LuGGlld:pubmed
pubmed-article:12028540pubmed:authorpubmed-author:InokumaHHlld:pubmed
pubmed-article:12028540pubmed:authorpubmed-author:KhatlaniT STSlld:pubmed
pubmed-article:12028540pubmed:issnTypePrintlld:pubmed
pubmed-article:12028540pubmed:volume59lld:pubmed
pubmed-article:12028540pubmed:ownerNLMlld:pubmed
pubmed-article:12028540pubmed:authorsCompleteYlld:pubmed
pubmed-article:12028540pubmed:pagination127-32lld:pubmed
pubmed-article:12028540pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:12028540pubmed:meshHeadingpubmed-meshheading:12028540...lld:pubmed
pubmed-article:12028540pubmed:meshHeadingpubmed-meshheading:12028540...lld:pubmed
pubmed-article:12028540pubmed:meshHeadingpubmed-meshheading:12028540...lld:pubmed
pubmed-article:12028540pubmed:meshHeadingpubmed-meshheading:12028540...lld:pubmed
pubmed-article:12028540pubmed:meshHeadingpubmed-meshheading:12028540...lld:pubmed
pubmed-article:12028540pubmed:meshHeadingpubmed-meshheading:12028540...lld:pubmed
pubmed-article:12028540pubmed:meshHeadingpubmed-meshheading:12028540...lld:pubmed
pubmed-article:12028540pubmed:meshHeadingpubmed-meshheading:12028540...lld:pubmed
pubmed-article:12028540pubmed:meshHeadingpubmed-meshheading:12028540...lld:pubmed
pubmed-article:12028540pubmed:meshHeadingpubmed-meshheading:12028540...lld:pubmed
pubmed-article:12028540pubmed:meshHeadingpubmed-meshheading:12028540...lld:pubmed
pubmed-article:12028540pubmed:meshHeadingpubmed-meshheading:12028540...lld:pubmed
pubmed-article:12028540pubmed:meshHeadingpubmed-meshheading:12028540...lld:pubmed
pubmed-article:12028540pubmed:year2002lld:pubmed
pubmed-article:12028540pubmed:articleTitleMolecular cloning and sequencing of feline melanoma antigen 2 (fMAGE-2) obtained from a lymphoma cell line.lld:pubmed
pubmed-article:12028540pubmed:affiliationLaboratory of Veterinary Internal Medicine, Faculty of Agriculture, Yamaguchi University, Yamaguchi, Japan.lld:pubmed
pubmed-article:12028540pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12028540pubmed:publicationTypeComparative Studylld:pubmed
entrez-gene:493792entrezgene:pubmedpubmed-article:12028540lld:entrezgene